AVXL News
Anavex Life Sciences Corp.
$1.28
-$0.04(-2.67%)
--
Overall
--
Value
--
Tech
--
Quality
Market Cap
--
Volume
542.90K
52W Range
$1.30 - $9.50
Target Price
--
AVXL news: the latest Anavex Life Sciences Corp. headlines, press releases and market updates, newest first.
Latest AVXL News
- Anavex Advances Blarcamesine Clinical Pharmacology and Rare-Disease ProgramsTipRanks Auto-Generated Newsdesk · Oct 20, 2026
- Anavex IND Cleared for Fragile X Syndrome TrialTipRanks Auto-Generated Newsdesk · Oct 15, 2026
- Anavex Life Sciences (AVXL) Faces Securities Lawsuit After CEO Firing and Admission of Ineffective Internal ControlsJoseph E. Levi · Oct 8, 2026
- Anavex Life Sciences Corp. (NASDAQ: AVXL) Faces Securities Lawsuit Following Internal Control and CEO-Related Disclosures and Stock DeclinesJoseph E. Levi · Oct 2, 2026
- Anavex Shareholders Back Board Slate in Contested MeetingTipRanks Auto-Generated Newsdesk · Sep 28, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVXL | $1.28 | -2.7% | 542.90K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Anavex Life Sciences Corp. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW